Clioquinol-induced increase and decrease in the intracellular Zn 2 + level in rat thymocytes

Life Sciences

Volumn 91, Issue 23-24, 2012, Pages 1216-1220

  Oyama, Tomohiro M ^a,b   Ishida, Shiro ^a,c   Okano, Yoshiro ^a,c   Seo, Hakaru ^a,d   Oyama, Yasuo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Medical Co LTA Clinical Pharmacology Center   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^d SOJO UNIVERSITY   (Japan)

Author keywords

Chelator; Clioquinol; Cytotoxicity; FluoZin 3; Intracellular Zn2 +

Indexed keywords

CLIOQUINOL; FLUORESCENT DYE; FLUOZIN 3; UNCLASSIFIED DRUG; ZINC;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; CHELATION; DRUG CYTOTOXICITY; EXTRACELLULAR ZINC; FLOW CYTOMETRY; FLUORESCENCE; INTRACELLULAR TRANSPORT; INTRACELLULAR ZINC LEVEL; NONHUMAN; RAT; THYMOCYTE;

ANIMALS; CHELATING AGENTS; CLIOQUINOL; FLOW CYTOMETRY; FLUORESCENCE; PENTETIC ACID; POLYCYCLIC COMPOUNDS; RATS; THYMOCYTES; ZINC;

RATTUS;

EID: 84869494159     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.09.014     Document Type: Article

References (41)

1. 2 + Proc Natl Acad Sci U S A 106 2009 8374 8379
2. C.S. Atwood, R.C. Scarpa, X. Huang, R.D. Moir, W.D. Jones, and D.P. Fairlie Characterization of copper interactions with Alzheimer amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid β1-42 J Neurochem 75 2000 1219 1233
3. D. Barbieri, L. Troiano, E. Grassilli, C. Agnesini, E.A. Cristofalo, and D. Monti Inhibition of apoptosis by zinc: a reappraisal Biochem Biophys Res Commun 187 1992 1256 1261
4. W.J. Bettger, and B.L. O'Dell A critical physiological role of zinc in the structure and function of biomembranes Life Sci 28 1981 1425 1438
5. S. Bolognin, D. Drago, L. Messori, and P. Zatta Chelation therapy for neurodegenerative diseases Med Res Rev 29 2009 547 570
6. T.M. Bray, and W.J. Bettger The physiological role of zinc as an antioxidant Free Radic Biol Med 8 1990 281 291
7. L. Cai, X.K. Li, Y. Song, and M.G. Cherian Essentiality, toxicology and chelation therapy of zinc and copper Curr Med Chem 12 2005 2753 2763
8. M. Capasso, J.M. Jeng, M. Malavolta, E. Mocchegiani, and S.L. Sensi Zinc dyshomeostasis: a key modulator of neuronal injury J Alzheimers Dis 8 2005 93 108
9. R.A. Cherny, C.S. Atwood, M.E. Xilinas, D.N. Gray, W.D. Jones, and C.A. McLean Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 2001 665 676
10. 2-induced changes in cell viability and cellular nonprotein thiol level of dissociated rat thymocytes Jpn J Pharmacol 71 1996 299 305
11. 2 + signals during monochloramine-induced oxidative stress in isolated rat colon crypts Am J Physiol Gastrointest Liver Physiol 290 2006 G250 G261
12. J.E. Cummings, and J.P. Kovacic The ubiquitous role of zinc in health and disease J Vet Emerg Crit Care (San Antonio) 19 2009 215 240
13. S. Cunningham-Rundles, R.S. Bockman, A. Lin, P.V. Giardina, M.W. Hilgartner, and D. Caldwell-Brown Physiological and pharmacological effects of zinc on immune response Ann N Y Acad Sci 587 1990 113 122
14. C.C. Curtain, F. Ali, I. Volitakis, R.A. Cherny, R.S. Norton, and K. Beyreuther Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits J Biol Chem 276 2001 20466 20473
15. K.G. Daniel, D. Chen, S. Orlu, Q.C. Cui, F.R. Miller, and Q.P. Dou Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Res 7 2005 R897 R908
16. C.J. Frederickson, W. Maret, and M.P. Cuajungco Zinc and excitotoxic brain injury: a new model Neuroscientist 10 2004 18 25
17. T. Fukada, S. Yamasaki, K. Nishida, M. Murakami, and T. Hirano Zinc homeostasis and signaling in health and diseases: zinc signaling J Biol Inorg Chem 16 2011 1123 1134
18. K.R. Gee, Z.L. Zhou, W.J. Qian, and R. Kennedy Detection and imaging of zinc secretion from pancreatic beta-cells using a new fluorescent zinc indicator J Am Chem Soc 124 2002 776 778
19. R.C. Gracia, and W.R. Snodgrass Lead toxicity and chelation therapy Am J Health Syst Pharm 64 2007 45 53
20. H. Haase, and L. Rink The immune system and the impact of zinc during aging Immun Ageing 6 2009 9
21. H. Haase, S. Overbeck, and L. Rink Zinc supplementation for the treatment or prevention of disease: current status and future perspectives Exp Gerontol 43 2008 394 408
22. M.L. Hegde, P. Bharathi, A. Suram, C. Venugopal, R. Jagannathan, and P. Poddar Challenges associated with metal chelation therapy in Alzheimer's disease J Alzheimers Dis 17 2009 457 468
23. D.K. Heyland, N. Jones, N.Z. Cvijanovich, and H. Wong Zinc supplementation in critically ill patients: a key pharmaconutrient? J Parenter Enteral Nutr 32 2008 509 519
24. J.P. Kao, A.T. Harootunian, and R.Y. Tsien Photochemically generated cytosolic calcium pulses and their detection by fluo-3 J Biol Chem 264 1989 8179 8184
25. 2 + release during oxidative stress: a trigger to restore cellular thiol content that is decreased by oxidative stress J Physiol Sci 61 2011 403 409
26. K.D. Kröncke Cellular stress and intracellular zinc dyshomeostasis Arch Biochem Biophys 463 2007 183 187
27. L. Lannfelt, K. Blennow, H. Zetterberg, S. Batsman, D. Ames, and J. Harrison Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled Lancet Neurol 7 2008 779 786
28. K.H. Maclean, J.L. Cleveland, and J.B. Porter Cellular zinc content is a major determinant of iron chelator-induced apoptosis of thymocytes Blood 98 2001 3831 3839
29. X. Mao, and A.D. Schimmer The toxicology of clioquinol Toxicol Lett 182 2008 1 6
30. W. Maret, and H.H. Sandstead Zinc requirements and the risks and benefits of zinc supplementation J Trace Elem Med Biol 20 2006 3 18
31. 2 + permeability in rat thymocytes: possible contribution to their cytotoxicity Toxicology 248 2008 142 150
32. M.J. McCabe, A.J. Shun, and S. Orrenius Chelation of intracellular zinc triggers apoptosis in mature thymocytes Lab Invest 69 1993 101 110
33. A. Minta, J.P. Kao, and R.Y. Tsien Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores J Biol Chem 264 1989 8171 8178
34. M.H. Park, S.J. Lee, H.R. Byun, Y. Kim, Y.J. Oh, and J.Y. Koh Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore Neurobiol Dis 42 2011 242 251
35. A.S. Prasad Zinc: role in immunity, oxidative stress and chronic inflammation Curr Opin Clin Nutr Metab Care 12 2009 646 652
36. M. Provinciali, G. Di Stefano, and N. Fabris Dose-dependent opposite effect of zinc on apoptosis in mouse thymocytes Int J Immunopharmacol 17 1995 735 744
37. B. Raman, T. Ban, K.I. Yamaguchi, M. Sakai, T. Kawai, and H. Naiki Metal ion-dependent effects of clioquinol on the fibril growth of an amyloid β peptide J Biol Chem 280 2005 16157 16162
38. C.W. Ritchie, A.I. Bush, A. Mackinnon, S. Macfarlane, M. Mastwyk, and L. MacGregor Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting a β amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch Neurol 60 2003 1685 1691
39. 2 +-dependent cell death induced by A23187, calcium ionophore, in rat thymocytes Toxicol In Vitro 23 2009 338 345
40. A.H. Shankar, and A.S. Prasad Zinc and immune function: the biological basis of altered resistance to infection Am J Clin Nutr 68 1998 447S 463S
41. T. Wang, W. Zheng, H. Xu, J.M. Zhou, and Z.Y. Wang Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model PLoS One 5 2010 e11888